Cargando…

Autoimmune Regulator (AIRE) Deficiency Does Not Affect Atherosclerosis and CD4 T Cell Immune Tolerance to Apolipoprotein B

Atherosclerosis is a chronic, lipid-driven disease of medium sized arteries which causes myocardial infarction and stroke. Recently, an adaptive immune response against the plaque-associated autoantigen Apolipoprotein B100 (ApoB), the structural protein component of low-density lipoprotein, has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Nettersheim, Felix Sebastian, Braumann, Simon, Kobiyama, Kouji, Orecchioni, Marco, Vassallo, Melanie, Miller, Jacqueline, Ali, Amal, Roy, Payel, Saigusa, Ryosuke, Wolf, Dennis, Ley, Klaus, Winkels, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792778/
https://www.ncbi.nlm.nih.gov/pubmed/35097028
http://dx.doi.org/10.3389/fcvm.2021.812769
_version_ 1784640454018465792
author Nettersheim, Felix Sebastian
Braumann, Simon
Kobiyama, Kouji
Orecchioni, Marco
Vassallo, Melanie
Miller, Jacqueline
Ali, Amal
Roy, Payel
Saigusa, Ryosuke
Wolf, Dennis
Ley, Klaus
Winkels, Holger
author_facet Nettersheim, Felix Sebastian
Braumann, Simon
Kobiyama, Kouji
Orecchioni, Marco
Vassallo, Melanie
Miller, Jacqueline
Ali, Amal
Roy, Payel
Saigusa, Ryosuke
Wolf, Dennis
Ley, Klaus
Winkels, Holger
author_sort Nettersheim, Felix Sebastian
collection PubMed
description Atherosclerosis is a chronic, lipid-driven disease of medium sized arteries which causes myocardial infarction and stroke. Recently, an adaptive immune response against the plaque-associated autoantigen Apolipoprotein B100 (ApoB), the structural protein component of low-density lipoprotein, has been implicated in atherogenesis. In healthy individuals, CD4(+) T cells responding to ApoB mainly comprised regulatory T cells, which confer immune tolerance and atheroprotection. Mice and patients with atherosclerosis harbor increased numbers of proatherogenic ApoB-reactive T-helper cell subsets. Given the lack of therapies targeting proatherogenic immunity, clarification of the underlying mechanisms is of high clinical relevance. T cells develop in the thymus, where strong autoreactive T cells are eliminated in the process of negative selection. Herein, we investigated whether the transcription factor autoimmune regulator (AIRE), which controls expression of numerous tissue-restricted self-antigens in the thymus, is involved in mediating tolerance to ApoB and whether Aire deficiency might contribute to atherogenesis. Mice deficient for Aire were crossbred to apolipoprotein E-deficient mice to obtain atherosclerosis-prone Aire(−/−) Apoe(−/−) mice, which were fed a regular chow diet (CD) or western-type diet (WD). CD4(+) T cells responding to the ApoB peptide p6 were analyzed by flow cytometry. We demonstrate that Aire deficiency influences neither generation nor activation of ApoB-reactive T cells and has only minor and overall inconsistent impacts on their phenotype. Furthermore, we show that atherosclerotic plaque size is not affected in Aire(−/−) Apoe(−/−) compared to Aire(+/+) Apoe(−/−), irrespective of diet and gender. In conclusion, our data suggests that AIRE is not involved in regulating thymic expression of ApoB or atherosclerosis. Alternative mechanisms how ApoB-reactive CD4 T cells are selected in the thymus will have to be investigated.
format Online
Article
Text
id pubmed-8792778
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87927782022-01-28 Autoimmune Regulator (AIRE) Deficiency Does Not Affect Atherosclerosis and CD4 T Cell Immune Tolerance to Apolipoprotein B Nettersheim, Felix Sebastian Braumann, Simon Kobiyama, Kouji Orecchioni, Marco Vassallo, Melanie Miller, Jacqueline Ali, Amal Roy, Payel Saigusa, Ryosuke Wolf, Dennis Ley, Klaus Winkels, Holger Front Cardiovasc Med Cardiovascular Medicine Atherosclerosis is a chronic, lipid-driven disease of medium sized arteries which causes myocardial infarction and stroke. Recently, an adaptive immune response against the plaque-associated autoantigen Apolipoprotein B100 (ApoB), the structural protein component of low-density lipoprotein, has been implicated in atherogenesis. In healthy individuals, CD4(+) T cells responding to ApoB mainly comprised regulatory T cells, which confer immune tolerance and atheroprotection. Mice and patients with atherosclerosis harbor increased numbers of proatherogenic ApoB-reactive T-helper cell subsets. Given the lack of therapies targeting proatherogenic immunity, clarification of the underlying mechanisms is of high clinical relevance. T cells develop in the thymus, where strong autoreactive T cells are eliminated in the process of negative selection. Herein, we investigated whether the transcription factor autoimmune regulator (AIRE), which controls expression of numerous tissue-restricted self-antigens in the thymus, is involved in mediating tolerance to ApoB and whether Aire deficiency might contribute to atherogenesis. Mice deficient for Aire were crossbred to apolipoprotein E-deficient mice to obtain atherosclerosis-prone Aire(−/−) Apoe(−/−) mice, which were fed a regular chow diet (CD) or western-type diet (WD). CD4(+) T cells responding to the ApoB peptide p6 were analyzed by flow cytometry. We demonstrate that Aire deficiency influences neither generation nor activation of ApoB-reactive T cells and has only minor and overall inconsistent impacts on their phenotype. Furthermore, we show that atherosclerotic plaque size is not affected in Aire(−/−) Apoe(−/−) compared to Aire(+/+) Apoe(−/−), irrespective of diet and gender. In conclusion, our data suggests that AIRE is not involved in regulating thymic expression of ApoB or atherosclerosis. Alternative mechanisms how ApoB-reactive CD4 T cells are selected in the thymus will have to be investigated. Frontiers Media S.A. 2022-01-13 /pmc/articles/PMC8792778/ /pubmed/35097028 http://dx.doi.org/10.3389/fcvm.2021.812769 Text en Copyright © 2022 Nettersheim, Braumann, Kobiyama, Orecchioni, Vassallo, Miller, Ali, Roy, Saigusa, Wolf, Ley and Winkels. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Nettersheim, Felix Sebastian
Braumann, Simon
Kobiyama, Kouji
Orecchioni, Marco
Vassallo, Melanie
Miller, Jacqueline
Ali, Amal
Roy, Payel
Saigusa, Ryosuke
Wolf, Dennis
Ley, Klaus
Winkels, Holger
Autoimmune Regulator (AIRE) Deficiency Does Not Affect Atherosclerosis and CD4 T Cell Immune Tolerance to Apolipoprotein B
title Autoimmune Regulator (AIRE) Deficiency Does Not Affect Atherosclerosis and CD4 T Cell Immune Tolerance to Apolipoprotein B
title_full Autoimmune Regulator (AIRE) Deficiency Does Not Affect Atherosclerosis and CD4 T Cell Immune Tolerance to Apolipoprotein B
title_fullStr Autoimmune Regulator (AIRE) Deficiency Does Not Affect Atherosclerosis and CD4 T Cell Immune Tolerance to Apolipoprotein B
title_full_unstemmed Autoimmune Regulator (AIRE) Deficiency Does Not Affect Atherosclerosis and CD4 T Cell Immune Tolerance to Apolipoprotein B
title_short Autoimmune Regulator (AIRE) Deficiency Does Not Affect Atherosclerosis and CD4 T Cell Immune Tolerance to Apolipoprotein B
title_sort autoimmune regulator (aire) deficiency does not affect atherosclerosis and cd4 t cell immune tolerance to apolipoprotein b
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792778/
https://www.ncbi.nlm.nih.gov/pubmed/35097028
http://dx.doi.org/10.3389/fcvm.2021.812769
work_keys_str_mv AT nettersheimfelixsebastian autoimmuneregulatorairedeficiencydoesnotaffectatherosclerosisandcd4tcellimmunetolerancetoapolipoproteinb
AT braumannsimon autoimmuneregulatorairedeficiencydoesnotaffectatherosclerosisandcd4tcellimmunetolerancetoapolipoproteinb
AT kobiyamakouji autoimmuneregulatorairedeficiencydoesnotaffectatherosclerosisandcd4tcellimmunetolerancetoapolipoproteinb
AT orecchionimarco autoimmuneregulatorairedeficiencydoesnotaffectatherosclerosisandcd4tcellimmunetolerancetoapolipoproteinb
AT vassallomelanie autoimmuneregulatorairedeficiencydoesnotaffectatherosclerosisandcd4tcellimmunetolerancetoapolipoproteinb
AT millerjacqueline autoimmuneregulatorairedeficiencydoesnotaffectatherosclerosisandcd4tcellimmunetolerancetoapolipoproteinb
AT aliamal autoimmuneregulatorairedeficiencydoesnotaffectatherosclerosisandcd4tcellimmunetolerancetoapolipoproteinb
AT roypayel autoimmuneregulatorairedeficiencydoesnotaffectatherosclerosisandcd4tcellimmunetolerancetoapolipoproteinb
AT saigusaryosuke autoimmuneregulatorairedeficiencydoesnotaffectatherosclerosisandcd4tcellimmunetolerancetoapolipoproteinb
AT wolfdennis autoimmuneregulatorairedeficiencydoesnotaffectatherosclerosisandcd4tcellimmunetolerancetoapolipoproteinb
AT leyklaus autoimmuneregulatorairedeficiencydoesnotaffectatherosclerosisandcd4tcellimmunetolerancetoapolipoproteinb
AT winkelsholger autoimmuneregulatorairedeficiencydoesnotaffectatherosclerosisandcd4tcellimmunetolerancetoapolipoproteinb